MDPI and ACS Style
Wen, Y.-T.; Wu, A.T.; Bamodu, O.A.; Wei, L.; Lin, C.-M.; Yen, Y.; Chao, T.-Y.; Mukhopadhyay, D.; Hsiao, M.; Huang, H.-S.
A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis. Cancers 2019, 11, 1442.
https://doi.org/10.3390/cancers11101442
AMA Style
Wen Y-T, Wu AT, Bamodu OA, Wei L, Lin C-M, Yen Y, Chao T-Y, Mukhopadhyay D, Hsiao M, Huang H-S.
A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis. Cancers. 2019; 11(10):1442.
https://doi.org/10.3390/cancers11101442
Chicago/Turabian Style
Wen, Ya-Ting, Alexander TH Wu, Oluwaseun Adebayo Bamodu, Li Wei, Chien-Min Lin, Yun Yen, Tsu-Yi Chao, Debabrata Mukhopadhyay, Michael Hsiao, and Hsu-Shan Huang.
2019. "A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis" Cancers 11, no. 10: 1442.
https://doi.org/10.3390/cancers11101442